Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology of Skeletal Health in Type 1 Diabetes

  • Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)
  • Published:
Current Osteoporosis Reports Aims and scope Submit manuscript

Abstract

The skeleton is adversely affected by type 1 diabetes (T1D). Patients with T1D of both sexes have an increased risk of fracture that begins in childhood and extends across the entire lifespan. T1D is characterized by mild to modest deficits in bone density, structure, and microarchitecture. Current evidence suggests that the observed bone deficits in T1D are the result of impaired bone formation rather than increased bone resorption. There is emerging data that bone quality is impaired in T1D, which may explain the findings that fracture risk is elevated out of proportion to the degree of bone mineral deficit. In this review, we summarize the current knowledge regarding the epidemiology of skeletal health in T1D. Given the high individual and societal burden of osteoporotic fracture, there is an urgent need to better understand the etiology of T1D-related bone disease so that clinical strategies to prevent fracture can be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance ••Of major importance

  1. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–97.

    Article  PubMed  PubMed Central  Google Scholar 

  2. American Diabetes Association. Children and adolescents. Sec. 11. in Standards of medical care in diabetes-2015. Diabetes Care. 2015;38 Suppl 1:S70–S6.

    Article  Google Scholar 

  3. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–90.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Forsen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia. 1999;42(8):920–5.

    Article  CAS  PubMed  Google Scholar 

  5. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001;24(7):1192–7.

    Article  CAS  PubMed  Google Scholar 

  6. Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W. Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care. 2005;28(12):2850–5.

    Article  PubMed  Google Scholar 

  7. Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48(7):1292–9.

    Article  CAS  PubMed  Google Scholar 

  8. Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care. 2006;29(7):1573–8.

    Article  PubMed  Google Scholar 

  9. Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H. Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int. 2006;17(4):495–500.

    Article  PubMed  Google Scholar 

  10. Hothersall EJ, Livingstone SJ, Looker HC, Ahmed SF, Cleland S, Leese GP, et al. Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. J Bone Miner Res. 2014;29(5):1054–60. Large registry study illustrating increased risk of hip fracture in patients with type 1 diabetes.

    Article  PubMed  Google Scholar 

  11. Fraser LA, Papaioannou A, Adachi JD, Ma J, Thabane L. Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study. BMC Musculoskelet Disord. 2014;15:201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, et al. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care. 2014;37(8):2246–52. Large population based study illustrating increased risk of incident fracture in patients with T1D.

    Article  PubMed  Google Scholar 

  13. Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care. 2015;38(10):1913–20. Large population based study illustrating that the increased fracture risk in patients with type 1 diabetes begins in childhood and extends across the entire lifespan.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, Shepelkevich AP, Zhurava IV, Korolenko GG, et al. Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013;36(6):1635–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2007;18(4):427–44.

    Article  CAS  PubMed  Google Scholar 

  16. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166(5):495–505.

    Article  PubMed  Google Scholar 

  17. Fan Y, Wei F, Lang Y, Liu Y. Diabetes mellitus and risk of hip fractures: a meta-analysis. Osteoporos Int. 2016;27(1):219–28.

    Article  CAS  PubMed  Google Scholar 

  18. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015;32(9):1134–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Neumann T, Samann A, Lodes S, Kastner B, Franke S, Kiehntopf M, et al. Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabet Med. 2011;28(7):872–5.

    Article  CAS  PubMed  Google Scholar 

  20. Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84(1):45–55.

    Article  CAS  PubMed  Google Scholar 

  21. Starup-Linde J, Lykkeboe S, Gregersen S, Hauge EM, Langdahl BL, Handberg A, et al. Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes. J Clin Endocrinol Metab. 2016;101(3):928–36. Study illustrating differences in the skeletal phenotype of type 1 vs type 2 diabetes.

    Article  CAS  PubMed  Google Scholar 

  22. No Authors. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86.

  23. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int. 1996;58(5):316–9.

    Article  CAS  PubMed  Google Scholar 

  24. Clausen P, Feldt-Rasmussen B, Jacobsen P, Rossing K, Parving HH, Nielsen PK, et al. Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients. Diabet Med. 1997;14(12):1038–43.

    Article  CAS  PubMed  Google Scholar 

  25. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22(7):1196–200.

    Article  CAS  PubMed  Google Scholar 

  26. Rozadilla A, Nolla JM, Montana E, Fiter J, Gomez-Vaquero C, Soler J, et al. Bone mineral density in patients with type 1 diabetes mellitus. Joint Bone Spine. 2000;67(3):215–8.

    CAS  PubMed  Google Scholar 

  27. Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, et al. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract. 2001;7(5):346–51.

    Article  CAS  PubMed  Google Scholar 

  28. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res. 2002;58(6):266–72.

    CAS  PubMed  Google Scholar 

  29. Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T. Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care. 2003;26(8):2365–9.

    Article  PubMed  Google Scholar 

  30. Moyer-Mileur LJ, Dixon SB, Quick JL, Askew EW, Murray MA. Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr. 2004;145(5):662–9.

    Article  PubMed  Google Scholar 

  31. Leger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Marchal CL, et al. Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J Clin Endocrinol Metab. 2006;91(10):3947–53.

    Article  CAS  PubMed  Google Scholar 

  32. Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care. 2006;29(2):306–11.

    Article  PubMed  Google Scholar 

  33. Miazgowski T, Pynka S, Noworyta-Zietara M, Krzyzanowska-Swiniarska B, Pikul R. Bone mineral density and hip structural analysis in type 1 diabetic men. Eur J Endocrinol. 2007;156(1):123–7.

    Article  CAS  PubMed  Google Scholar 

  34. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care. 2008;31(9):1729–35.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Danielson KK, Elliott ME, LeCaire T, Binkley N, Palta M. Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int. 2009;20(6):923–33.

    Article  CAS  PubMed  Google Scholar 

  36. Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, et al. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes. Diabet Med. 2009;26(1):45–52.

    Article  CAS  PubMed  Google Scholar 

  37. Heilman K, Zilmer M, Zilmer K, Tillmann V. Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels. J Bone Miner Metab. 2009;27(5):598–604.

    Article  CAS  PubMed  Google Scholar 

  38. Masse PG, Pacifique MB, Tranchant CC, Arjmandi BH, Ericson KL, Donovan SM, et al. Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected. J Am Coll Nutr. 2010;29(4):419–29.

    Article  CAS  PubMed  Google Scholar 

  39. Eller-Vainicher C, Zhukouskaya VV, Tolkachev YV, Koritko SS, Cairoli E, Grossi E, et al. Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis. Diabetes Care. 2011;34(10):2186–91.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Soto N, Pruzzo R, Eyzaguirre F, Iniguez G, Lopez P, Mohr J, et al. Bone mass and sex steroids in postmenarcheal adolescents and adult women with Type 1 diabetes mellitus. J Diabetes Complications. 2011;25(1):19–24.

    Article  PubMed  Google Scholar 

  41. Joshi A, Varthakavi P, Chadha M, Bhagwat N. A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. 2013;2013:397814.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41(11):1314–20.

    Article  CAS  PubMed  Google Scholar 

  43. Lunt H, Florkowski CM, Cundy T, Kendall D, Brown LJ, Elliot JR, et al. A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes. Diabetes Res Clin Pract. 1998;40(1):31–8.

    Article  CAS  PubMed  Google Scholar 

  44. Pascual J, Argente J, Lopez MB, Munoz M, Martinez G, Vazquez MA, et al. Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int. 1998;62(1):31–5.

    Article  CAS  PubMed  Google Scholar 

  45. Bridges MJ, Moochhala SH, Barbour J, Kelly CA. Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol. 2005;42(2):82–6.

    Article  CAS  PubMed  Google Scholar 

  46. Parthasarathy LS, Khadilkar VV, Chiplonkar SA, Zulf Mughal M, Khadilkar AV. Bone status of Indian children and adolescents with type 1 diabetes mellitus. Bone. 2016;82:16–20.

    Article  PubMed  Google Scholar 

  47. Shanbhogue VV, Hansen S, Frost M, Jorgensen NR, Hermann AP, Henriksen JE, et al. Bone Geometry, Volumetric Density, Microarchitecture, and Estimated Bone Strength Assessed by HR-pQCT in Adult Patients With Type 1 Diabetes Mellitus. J Bone Miner Res. 2015;30(12):2188–99. First study to use HR-pQCT to assess bone outcomes in type 1 diabetes.

    Article  CAS  PubMed  Google Scholar 

  48. Mosso C, Hodgson MI, Ortiz T, Reyes ML. Bone mineral density in young Chilean patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2016;29(6):731–6.

    Article  CAS  PubMed  Google Scholar 

  49. Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia-Cervigon AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int. 2000;11(5):455–9.

    Article  CAS  PubMed  Google Scholar 

  50. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14(5):525–8.

    Article  CAS  PubMed  Google Scholar 

  51. Pan H, Wu N, Yang T, He W. Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes Metab Res Rev. 2014;30(7):531–42.

    Article  PubMed  Google Scholar 

  52. Salvatoni A, Mancassola G, Biasoli R, Cardani R, Salvatore S, Broggini M, et al. Bone mineral density in diabetic children and adolescents: a follow-up study. Bone. 2004;34(5):900–4.

    Article  PubMed  Google Scholar 

  53. Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA et al. Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study. J Clin Endocrinol Metab. 2011;96(10):3160–9.

  54. Hamilton EJ, Rakic V, Davis WA, Paul Chubb SA, Kamber N, Prince RL, et al. A five-year prospective study of bone mineral density in men and women with diabetes: the Fremantle Diabetes Study. Acta Diabetol. 2012;49(2):153–8.

    Article  CAS  PubMed  Google Scholar 

  55. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, et al. Bone formation is impaired in a model of type 1 diabetes. Diabetes. 2005;54(10):2875–81.

    Article  CAS  PubMed  Google Scholar 

  56. Bechtold S, Dirlenbach I, Raile K, Noelle V, Bonfig W, Schwarz HP. Early manifestation of type 1 diabetes in children is a risk factor for changed bone geometry: data using peripheral quantitative computed tomography. Pediatrics. 2006;118(3):e627–34.

    Article  PubMed  Google Scholar 

  57. Roggen I, Gies I, Vanbesien J, Louis O, De Schepper J. Trabecular bone mineral density and bone geometry of the distal radius at completion of pubertal growth in childhood type 1 diabetes. Horm Res Paediatr. 2013;79(2):68–74.

    Article  CAS  PubMed  Google Scholar 

  58. Bechtold S, Putzker S, Bonfig W, Fuchs O, Dirlenbach I, Schwarz HP. Bone size normalizes with age in children and adolescents with type 1 diabetes. Diabetes Care. 2007;30(8):2046–50.

    Article  PubMed  Google Scholar 

  59. Abdalrahaman N, McComb C, Foster J, McLean J, Lindsay R, McClure J, et al. Deficits in Trabecular Bone Microarchitecture in Young Women with Type 1 Diabetes Mellitus. J Bone Miner Res. 2015;30:1386–93. First study using MRI to assess bone structural outcomes in T1D. Identified microvascular changes as a strong risk fracture for bone deficits.

    Article  CAS  PubMed  Google Scholar 

  60. Simmons KM, McFann K, Taki I, Liu E, Klingensmith GJ, Rewers MJ, et al. Reduced Bone Mineral Density Is Associated with Celiac Disease Autoimmunity in Children with Type 1 Diabetes. J Pediatr. 2016;169:44–8. e1.

    Article  PubMed  Google Scholar 

  61. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Risk Factors for Cardiovascular Disease in Type 1 Diabetes. Diabetes. 2016;65(5):1370–9.

  62. Saito M, Kida Y, Kato S, Marumo K. Diabetes, collagen, and bone quality. Curr Osteoporos Rep. 2014;12(2):181–8.

    Article  PubMed  Google Scholar 

  63. Neumann T, Lodes S, Kastner B, Franke S, Kiehntopf M, Lehmann T, et al. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int. 2014;25(5):1527–33.

    Article  CAS  PubMed  Google Scholar 

  64. Farlay D, Armas LA, Gineyts E, Akhter MP, Recker RR, Boivin G. Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus. J Bone Miner Res. 2016;31(1):190–5.

    Article  CAS  PubMed  Google Scholar 

  65. Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016;82:28–34.

    Article  CAS  PubMed  Google Scholar 

  66. Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P. Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int. 2014;25(6):1697–708.

    Article  CAS  PubMed  Google Scholar 

  67. Pater A, Sypniewska G, Pilecki O. Biochemical markers of bone cell activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2010;23(1–2):81–6.

    CAS  PubMed  Google Scholar 

  68. Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - A systematic review. Bone. 2016;82:69–78. Systematic review illustrating low bone turnover in type 1 diabetes.

    Article  CAS  PubMed  Google Scholar 

  69. Abd El Dayem SM, El-Shehaby AM, Abd El Gafar A, Fawzy A, Salama H. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest. 2011;71(5):387–93.

    Article  CAS  PubMed  Google Scholar 

  70. Neumann T, Hofbauer LC, Rauner M, Lodes S, Kastner B, Franke S, et al. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus. Clin Endocrinol (Oxf). 2014;80(5):649–55.

    Article  CAS  Google Scholar 

  71. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Lumpkin Jr CK, Fowlkes JL. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int. 2011.

  72. Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012;97(5):1737–44.

    Article  CAS  PubMed  Google Scholar 

  73. Starup-Linde J, Lykkeboe S, Gregersen S, Hauge EM, Langdahl BL, Handberg A, et al. Differences in biochemical bone markers by diabetes type and the impact of glucose. Bone. 2016;83:149–55.

    Article  CAS  PubMed  Google Scholar 

  74. Armas LA, Akhter MP, Drincic A, Recker RR. Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus. Bone. 2012;50(1):91–6.

    Article  PubMed  Google Scholar 

  75. Janner M, Ballinari P, Mullis PE, Fluck CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly. 2010;140:w13091.

    PubMed  Google Scholar 

  76. The NS, Crandell JL, Lawrence JM, King IB, Dabelea D, Marcovina SM, et al. Vitamin D in youth with Type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabet Med. 2013;30(11):1324–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Wood JR, Connor CG, Cheng P, Ruedy KJ, Tamborlane WV, Klingensmith G et al. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatr Diabetes. 2015. doi:10.1111/pedi.12340. Study illustrating that rate of vitamin D deficiency in type 1 diabetes are similar to general population.

  78. Thorsen SU, Mortensen HB, Carstensen B, Fenger M, Thuesen BH, Husemoen LL, et al. No difference in vitamin D levels between children newly diagnosed with type 1 diabetes and their healthy siblings: a 13-year nationwide Danish study. Diabetes Care. 2013;36(9):e157–8.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, et al. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporos Int. 2016;27(4):1631–43.

    Article  CAS  PubMed  Google Scholar 

  80. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab. 2011;96(1):142–9.

    Article  CAS  PubMed  Google Scholar 

  81. Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol. 2015;22:41–50.

    Article  CAS  PubMed  Google Scholar 

  82. Azab SF, Saleh SH, Elsaeed WF, Abdelsalam SM, Ali AA, Esh AM. Vitamin D status in diabetic Egyptian children and adolescents: a case–control study. Ital J Pediatr. 2013;39:73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Schwarz P, Sorensen HA, Momsen G, Friis T, Transbol I, McNair P. Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. Acta Endocrinol (Copenh). 1992;126(3):260–3.

    CAS  Google Scholar 

  84. Raskin P, Stevenson MR, Barilla DE, Pak CY. The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf). 1978;9(4):329–35.

    Article  CAS  Google Scholar 

  85. McNair P, Madsbad S, Christensen MS, Christiansen C, Faber OK, Binder C, et al. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh). 1979;90(3):463–72.

    CAS  Google Scholar 

  86. Witt MF, White NH, Santiago JV, Seino Y, Avioli LV. Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics. J Clin Endocrinol Metab. 1983;57(1):94–100.

    Article  CAS  PubMed  Google Scholar 

  87. Malone JI, Lowitt S, Duncan JA, Shah SC, Vargas A, Root AW. Hypercalciuria, hyperphosphaturia, and growth retardation in children with diabetes mellitus. Pediatrics. 1986;78(2):298–304.

    CAS  PubMed  Google Scholar 

  88. Hough FS. Alterations of bone and mineral metabolism in diabetes mellitus. Part II. Clinical studies in 206 patients with type I diabetes mellitus. S Afr Med J. 1987;72(2):120–6.

    CAS  PubMed  Google Scholar 

  89. Brown IR, McBain AM, Chalmers J, Campbell IW, Brown ER, Lewis MJ. Sex difference in the relationship of calcium and magnesium excretion to glycaemic control in type 1 diabetes mellitus. Clin Chim Acta. 1999;283(1–2):119–28.

    Article  CAS  PubMed  Google Scholar 

  90. Ersoy B, Darcan S, Goksen D, Coker M, Mavi E. Hypercalciuria and Hyperphosphaturia in Insulin Dependent Diabetes Mellitus. Turk J Endocrinol Metab. 1999;4:177–80.

    Google Scholar 

  91. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003;63(2):662–9.

    Article  CAS  PubMed  Google Scholar 

  92. Ingberg CM, Palmer M, Aman J, Arvidsson B, Schvarcz E, Berne C. Body composition and bone mineral density in long-standing type 1 diabetes. J Intern Med. 2004;255(3):392–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology, University of Rochester, 601 Elmwood Ave, Box 690, Rochester, NY, 14642, USA

    David R. Weber

  2. Division of Pediatric Nephrology, University of Rochester, 601 Elmwood Ave, Box 690, Rochester, NY, 14642, USA

    George Schwartz

Authors
  1. David R. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David R. Weber.

Ethics declarations

Conflict of Interest

George Schwartz reports grants from the National Institutes of Health during the conduct of the study.

David Weber reports grants from National Institutes of Health, K12HD068373 during the conduct of the study.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Bone and Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, D.R., Schwartz, G. Epidemiology of Skeletal Health in Type 1 Diabetes. Curr Osteoporos Rep 14, 327–336 (2016). https://doi.org/10.1007/s11914-016-0333-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11914-016-0333-0

Keywords

Search

Navigation